DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT01472432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Registry
-
NCT01472432
-
- Other papers using this trial's data
- Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01472432. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2016-01 (actual). Results posted on 2015-06-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
- Condition
- Chronic Foot Ulcers
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- vildagliptin
- Lead sponsor
- University of Campania Luigi Vanvitelli
Record details
- Record id
cardio:ct-nct01472432- Content hash
3ef20663f650201ed3da89cdcffba52f5fa09e67b1b15bbb6ad514d1b00a4893